EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer

Hiroyuki Yamamoto, Yuhki Yokoyama, Shihori Kouda, Ruijia Yang, Yingjue Zhang, Jiaqi Wang, Yoshihiro Morimoto iD, Tsuyoshi Hata, Akira Inoue, Daisuke Okuzaki iD, Naotsugu Haraguchi, Hidekazu Takahashi und 3 weitere

International Journal of Molecular Sciences · 21.04.2026 · 27 (8) · 3686

DOI: 10.3390/ijms27083686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.04.2026. Verfasst von Hiroyuki Yamamoto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, Suita 565-0871, Japan. Hauptthemen laut MEDLINE: MicroRNAs, Pancreatic Neoplasms, Neoplastic Stem Cells. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI Grants, Kagoshima Shinsangyo Sousei Investment Limited Partnership.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In pancreatic cancer, cancer stem-like cells (CSCs) contribute to tumor initiation, reduced drug sensitivity, and recurrence. Limited strategies are currently available to target this cell population. Here we used a proteasome-low CSC enrichment system to identify microRNAs that negatively regulate CSC-like properties. From PANC-1 cells expressing a ZsGreen–ODC degron reporter, a proteasome-low population was isolated through sequential fluorescence-activated cell sorting of ZsGreen-positive cells. Molecular and functional analyses confirmed the CSC-like phenotype of this cell population. Integrated in silico analysis was used to select 31 microRNAs predicted to target CSC-related molecules, which were then evaluated by in vitro viability-based screening to identify candidates that selectively suppressed the viability of CSC-like cells, relative to non-CSCs. Moreover, comprehensive miRNA expression profiling revealed that miR-136-5p was downregulated in the CSC-like population and was therefore selected for further analysis. Mechanistically, miR-136-5p directly targets the 3′ untranslated region of DCLK1 and reduces its expression, with a greater reduction in the short isoform. Finally, in a CSC-derived xenograft mouse model, systemic delivery of miR-136-5p using super carbonate apatite nanoparticles significantly suppressed tumor growth. Taken together, these findings suggest that miR-136-5p restoration may provide a therapeutic approach for targeting CSC-driven tumor growth in pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsPancreatic NeoplasmsNeoplastic Stem CellsHumansAnimalsGene Expression Regulation, NeoplasticCell Line, TumorMiceProtein Serine-Threonine KinasesDoublecortin-Like KinasesIntracellular Signaling Peptides and Proteins3' Untranslated RegionsXenograft Model Antitumor AssaysMice, Nude

Stichwörter der Autor:innen

DCLK1cancer stem-like cellsdrug sensitivitymiR-136-5pmiRNA-based therapypancreatic cancer

Substanzen

MicroRNAsProtein Serine-Threonine KinasesDCLK1 protein, humanMIRN136 microRNA, humanDoublecortin-Like KinasesIntracellular Signaling Peptides and Proteins3' Untranslated Regions

Autor:innen und Institutionen

  • Department of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, Suita 565-0871, Japan.
  • Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Suita 565-0871, Japan.
  • Department of Gastroenterological Surgery, Osaka General Medical Center, Osaka 558-8558, Japan.
  • Department of Gastroenterological Surgery, Ikeda City Hospital, Ikeda 563-8510, Japan.
  • Laboratory for Human Immunology (Single Cell Genomics), WPI Immunology Frontier Research Center, The University of Osaka, Suita 565-0871, Japan.
  • Department of Gastroenterological Surgery, Kindai University Nara Hospital, Ikoma 630-0293, Japan.

ORCID-Profile: Yoshihiro Morimoto, Daisuke Okuzaki, Hirofumi Yamamoto

Förderung

  • Japan Society for the Promotion of Science
  • JSPS KAKENHI Grants
  • Kagoshima Shinsangyo Sousei Investment Limited Partnership

Zitieren

APA

Yamamoto, H., Yokoyama, Y., Kouda, S., Yang, R., Zhang, Y., Wang, J., Morimoto, Y., Hata, T., Inoue, A., Okuzaki, D., Haraguchi, N., Takahashi, H., Shibata, S., Yamamoto, H., & Mori, M. (2026). miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer. International Journal of Molecular Sciences, 27(8), 3686. https://doi.org/10.3390/ijms27083686

Vancouver

Yamamoto H, Yokoyama Y, Kouda S, Yang R, Zhang Y, Wang J, et al. miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer. International Journal of Molecular Sciences. 2026;27(8):3686. doi:10.3390/ijms27083686

BibTeX
@article{Yamamoto2026,
  author = {Yamamoto, Hiroyuki and Yokoyama, Yuhki and Kouda, Shihori and Yang, Ruijia and Zhang, Yingjue and Wang, Jiaqi and Morimoto, Yoshihiro and Hata, Tsuyoshi and Inoue, Akira and Okuzaki, Daisuke and Haraguchi, Naotsugu and Takahashi, Hidekazu and Shibata, Satoshi and Yamamoto, Hirofumi and Mori, Masaki},
  title = {miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {8},
  pages = {3686},
  doi = {10.3390/ijms27083686}
}
Kostenlos starten →